Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-T: Treating To Target in Type 2 Diabetes
ISRCTN51125379Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Nov 2004
- Modality
- Recombinant Proteins and Enzymes, Peptides
01
Overview
Phase 2, randomised, open-label trial of insulin detemir, insulin aspart and biphasic insulin aspart in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Novo Nordisk. Started Nov 2004; status: completed.
02
Drugs
insulin detemirinsulin aspartbiphasic insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ISRCTN51125379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN51125379.